Long-term safety of fluticasone furoate nasal spray (FFNS) 110 μg once-daily in adults and adolescents with perennial allergic rhinitis

被引：0
|
作者：
Rosenblut, A.
Bardin, P.
Fokkens, W.
Faris, M.
Wu, W.
Caldwell, M.
Rinia, B.
机构：
[1] Clin Arauco, Jefe Unidad Otorrinolaringol, Santiago, Chile
[2] Monash Med Ctr, Dept Resp & Sleep Med, Clayton, Vic 3168, Australia
[3] Univ Amsterdam, Acad Med Ctr, Div Neurozintuigspecialsmen, NL-1105 AZ Amsterdam, Netherlands
[4] GlaxoSmithKline Inc, Greenford, Middx, England
[5] GlaxoSmithKline Inc, Resp MDC, Res Triangle Pk, NC USA
来源：
ALLERGY | 2007年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [21] Hypothalmamic-pituitary-adrenocorticaI axis safety of once-daily fluticasone furoate nasal spray 110 mcg in children with perennial allergic rhinitis supported by observed dosing via videophone
    Ratner, P.
    Tripathy, I.
    Sterling, R.
    Clements, D.
    Faris, M.
    Philpot, E.
    ALLERGY, 2007, 62 : 130 - 131
  • [22] Once daily fluticasone furoate* nasal spray (FFNS), a novel enhanced affinity steroid, provides 24-hour relief for the nasal symptoms of perennial allergic rhinitis (PAR)
    Nathan, R.
    Berger, W.
    Yang, W.
    Cheema, A.
    Silvey, M. J.
    Wu, W.
    Faris, M.
    Philpot, E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S65 - S65
  • [23] Long-Term Safety and Efficacy of Ciclesonide Nasal Spray in Adolescents with Perennial Allergic Rhinitis
    Prenner, B. M.
    Chervinsky, P.
    Miller, D. L.
    Raphael, G.
    Wingertzahn, M. A.
    Karafilidis, J.
    Huang, H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S132 - S132
  • [24] A novel enhanced-affinity corticosteroid, once daily fluticasone furoate nasal spray (FFNS), provides 24-hour relief for the nasal symptoms of perennial allergic rhinitis (PAR)
    Vasar, M.
    Houle, P.
    Douglass, J.
    Meltzer, E.
    Silvey, M.
    Wu, W.
    Caldwell, M.
    Philpot, E.
    ALLERGY, 2007, 62 : 227 - 227
  • [25] Once-daily mometasone furoate nasal spray: Efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis
    Davies, RJ
    Nelson, HS
    CLINICAL THERAPEUTICS, 1997, 19 (01) : 27 - 38
  • [26] Once-daily fluticasone furoate* nasal spray (FF) is safe and effective in the long-term treatment of perennial allergic rhinitis (PAR) in children ages 2 to 11 years - *USAN approved name
    Masperol, J. F.
    Rosenblut, A.
    Finn, A., Jr.
    Lim, J.
    Wu, W.
    Faris, M.
    Philpot, E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S304 - S304
  • [27] Long-term ocular safety of mometasone furoate nasal spray during treatment of perennial allergic rhinitis
    Bernstein, D.
    ALLERGY, 2008, 63 : 87 - 87
  • [28] Safety of fluticasone furoate* nasal spray in children with perennial allergic rhinitis (*USAN) approved name
    Maspero, J.
    Rosenblut, A.
    Finn, A.
    Lim, J.
    Wu, W.
    Philpot, E.
    ALLERGY, 2007, 62 : 381 - 381
  • [29] Once-daily fluticasone furoate* nasal spray (FFNS) 110mcg improves quality of life (QoL) in subjects with seasonal allergic rhinitis (SAR) during the ragweed season - *USAN approved name
    Given, J.
    Toler, T.
    Ellsworth, A.
    Stanford, R.
    Philpot, E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S304 - S304
  • [30] Effectiveness of fluticasone furoate 110 μg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen
    Jacobs, Robert
    Martin, Bruce
    Hampel, Frank
    Toler, William
    Ellsworth, Anna
    Philpot, Edward
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (06) : 1393 - 1401
12345